• Profluent, a Berkeley startup, has used generative AI technology to create new gene editors based on CRISPR. The company has used one of the AI-generated gene editors to edit human DNA, but it has yet to put any of them through clinical trials. While Profluent plans to open source the gene editors generated by its AI technology, it will not be open sourcing the AI technology itself. The project is part of a wider effort to build AI technologies that improve medical care.